The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.

Risk warning:

Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.

Today's key assessments and concerns

Citizens: Maintaining Avalo Therapeutics ( Avalo Therapeutics Inc(AVTX.US) ) rating at "Outperform Market", while raising the price target from $52 to $62.

BTIG: Maintaining a "buy" rating on Avalo Therapeutics ( Avalo Therapeutics Inc(AVTX.US) ), while raising the price target from $40 to $58.

Bernstein: Maintaining ServiceNow's ( ServiceNow, Inc.(NOW.US) rating at "Market Match", while raising the price target from $226 to $236.

Rothschild & Co: Initial rating for Celsius Holdings ( Celsius Holdings, Inc.(CELH.US) ) at "neutral", with a target price of $47.

Benchmark: Maintain Strategy's rating ( Strategy(MSTR.US) ) at "Buy", while lowering the price target from $705 to $570.

The symbol	Classification	Target price	Current price	Percentage of potential increase/decrease	(Classification) Agency
Avalo Therapeutics Inc(AVTX.US)	to lift	$62.0	$21.81	184.27%	Citizens
Avalo Therapeutics Inc(AVTX.US)	to lift	$58.0	$21.81	165.93%	BTIG
ServiceNow, Inc.(NOW.US)	to lift	$236.0	$89.05	165.02%	Bernstein
Klaviyo, Inc. Class A(KVYO.US)	to lift	$31.0	$15.81	96.08%	Citigroup
Viridian Therapeutics, Inc.(VRDN.US)	to lift	$34.0	$17.53	93.95%	RBC Capital
Celsius Holdings, Inc.(CELH.US)	Initial classification	$47.0	$32.8	43.29%	Rothschild & Co
Strategy(MSTR.US)	cut	$570.0	$186.82	205.11%	Benchmark
Alphatec Holdings, Inc.(ATEC.US)	cut	$16.0	$6.99	128.9%	JP Morgan
Klaviyo, Inc. Class A(KVYO.US)	cut	$35.0	$15.81	121.38%	Keybanc
uniQure N.V.(QURE.US)	cut	$50.0	$22.82	119.11%	HC Wainwright & Co.

comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)

Lifting

Benchmark: Maintaining a "buy" rating on Advanced Micro Devices, Inc.(AMD.US) stock, with a price target raised from $325 to $485.

DA Davidson: Maintaining a "buy" rating on Advanced Micro Devices Advanced Micro Devices, Inc.(AMD.US) ) stock, while raising the price target from $375 to $425.

Mizuho: Maintaining its "outperform" rating for Arm Holdings ( Arm Holdings(ARM.US) ), while raising its price target from $230 to $255.

Mizuho: Maintaining Dell Dell Technologies, Inc. Class C(DELL.US) rating at "Outperforming the Market," while raising the price target from $215 to $260.

Morgan Stanley: Maintaining a "Market-Similar Weight" rating for Lumentum Lumentum Holdings, Inc.(LITE.US) , while raising its price target from $710 to $900.

TD Cowen: Maintaining a "Hold" rating on Lumentum Holdings Lumentum Holdings, Inc.(LITE.US) ), while raising its price target from $875 to $995.

Tigress Financial: Maintaining a "buy" rating on Microsoft Microsoft Corporation(MSFT.US) ) stock, while raising the price target from $595 to $680.

BTIG: Maintain Strategy ( Strategy(MSTR.US) ) rating at "Buy", while raising the price target from $250 to $350.

Bernstein: Maintaining ServiceNow's ( ServiceNow, Inc.(NOW.US) rating at "Market Match", while raising the price target from $226 to $236.

Citigroup: Maintaining a "buy" rating on Palantir Technologies Palantir(PLTR.US) , while raising the price target from $210 to $225.

Citigroup: Maintaining a "neutral" rating on Super Micro Computer ( Super Micro Computer, Inc.(SMCI.US) ), while raising its price target from $25 to $31.

Keybanc: Maintaining Sterling Construction ( Sterling Infrastructure, Inc.(STRL.US) ) rating at "overweight", while raising the price target from $572 to $889.

First Coverage

Rothschild & Co: Initial rating for Celsius Holdings ( Celsius Holdings, Inc.(CELH.US) ) at "neutral", with a target price of $47.

Canaccord Genuity: Initial rating for Kymera Therapeutics ( Kymera Therapeutics, Inc.(KYMR.US) ) at "Buy", with a target price of $106.

reduction

Benchmark: Maintaining a "buy" rating for Coinbase Global Coinbase(COIN.US) ) stock, while lowering the price target from $267 to $260.

Benchmark: Maintain Strategy's rating ( Strategy(MSTR.US) ) at "Buy", while lowering the price target from $705 to $570.

Needham: Maintaining a "buy" rating on Upstart Holdings ( Upstart(UPST.US) ), while lowering the price target from $40 to $37.

Piper Sandler: Maintaining an "overweight" rating on Upstart Holdings ( Upstart(UPST.US) ), while lowering the price target from $56 to $46.

Wells Fargo: Maintaining Westlake's Westlake Corporation(WLK.US) ) rating at "Market Weight", while lowering the price target from $125 to $110.

Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.